IBDEI15H ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41819,1,3,0)
 ;;=3^Vulvodynia,Other
 ;;^UTILITY(U,$J,358.3,41819,1,4,0)
 ;;=4^N94.818
 ;;^UTILITY(U,$J,358.3,41819,2)
 ;;=^5015923
 ;;^UTILITY(U,$J,358.3,41820,0)
 ;;=N94.819^^159^2050^120
 ;;^UTILITY(U,$J,358.3,41820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41820,1,3,0)
 ;;=3^Vulvodynia,Unspec
 ;;^UTILITY(U,$J,358.3,41820,1,4,0)
 ;;=4^N94.819
 ;;^UTILITY(U,$J,358.3,41820,2)
 ;;=^5015924
 ;;^UTILITY(U,$J,358.3,41821,0)
 ;;=N94.89^^159^2050^88
 ;;^UTILITY(U,$J,358.3,41821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41821,1,3,0)
 ;;=3^Pelvic Congestion Syndrome
 ;;^UTILITY(U,$J,358.3,41821,1,4,0)
 ;;=4^N94.89
 ;;^UTILITY(U,$J,358.3,41821,2)
 ;;=^5015925
 ;;^UTILITY(U,$J,358.3,41822,0)
 ;;=Z01.411^^159^2050^60
 ;;^UTILITY(U,$J,358.3,41822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41822,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,41822,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,41822,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,41823,0)
 ;;=Z90.722^^159^2050^12
 ;;^UTILITY(U,$J,358.3,41823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41823,1,3,0)
 ;;=3^Acq Absence,Ovaries,Bilateral
 ;;^UTILITY(U,$J,358.3,41823,1,4,0)
 ;;=4^Z90.722
 ;;^UTILITY(U,$J,358.3,41823,2)
 ;;=^5063595
 ;;^UTILITY(U,$J,358.3,41824,0)
 ;;=Z90.721^^159^2050^13
 ;;^UTILITY(U,$J,358.3,41824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41824,1,3,0)
 ;;=3^Acq Absence,Ovaries,Unilateral
 ;;^UTILITY(U,$J,358.3,41824,1,4,0)
 ;;=4^Z90.721
 ;;^UTILITY(U,$J,358.3,41824,2)
 ;;=^5063594
 ;;^UTILITY(U,$J,358.3,41825,0)
 ;;=Z90.79^^159^2050^11
 ;;^UTILITY(U,$J,358.3,41825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41825,1,3,0)
 ;;=3^Acq Absence,Oth Genital Organs (Fallop Tubes)
 ;;^UTILITY(U,$J,358.3,41825,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,41825,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,41826,0)
 ;;=D27.0^^159^2050^20
 ;;^UTILITY(U,$J,358.3,41826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41826,1,3,0)
 ;;=3^Benign Neop,Right Ovary
 ;;^UTILITY(U,$J,358.3,41826,1,4,0)
 ;;=4^D27.0
 ;;^UTILITY(U,$J,358.3,41826,2)
 ;;=^5002086
 ;;^UTILITY(U,$J,358.3,41827,0)
 ;;=D27.1^^159^2050^19
 ;;^UTILITY(U,$J,358.3,41827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41827,1,3,0)
 ;;=3^Benign Neop,Left Ovary
 ;;^UTILITY(U,$J,358.3,41827,1,4,0)
 ;;=4^D27.1
 ;;^UTILITY(U,$J,358.3,41827,2)
 ;;=^5002087
 ;;^UTILITY(U,$J,358.3,41828,0)
 ;;=D06.7^^159^2050^27
 ;;^UTILITY(U,$J,358.3,41828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41828,1,3,0)
 ;;=3^Carcinoma in Situ,Oth Parts of Cervix
 ;;^UTILITY(U,$J,358.3,41828,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,41828,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,41829,0)
 ;;=N84.1^^159^2050^31
 ;;^UTILITY(U,$J,358.3,41829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41829,1,3,0)
 ;;=3^Cervical Polyps
 ;;^UTILITY(U,$J,358.3,41829,1,4,0)
 ;;=4^N84.1
 ;;^UTILITY(U,$J,358.3,41829,2)
 ;;=^5015866
 ;;^UTILITY(U,$J,358.3,41830,0)
 ;;=N83.0^^159^2050^35
 ;;^UTILITY(U,$J,358.3,41830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41830,1,3,0)
 ;;=3^Cyst,Ovarian
 ;;^UTILITY(U,$J,358.3,41830,1,4,0)
 ;;=4^N83.0
 ;;^UTILITY(U,$J,358.3,41830,2)
 ;;=^5015854
 ;;^UTILITY(U,$J,358.3,41831,0)
 ;;=N80.3^^159^2050^48
 ;;^UTILITY(U,$J,358.3,41831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41831,1,3,0)
 ;;=3^Endometriosis,Pelvic
 ;;^UTILITY(U,$J,358.3,41831,1,4,0)
 ;;=4^N80.3
 ;;^UTILITY(U,$J,358.3,41831,2)
 ;;=^270486
 ;;^UTILITY(U,$J,358.3,41832,0)
 ;;=D25.1^^159^2050^70
 ;;^UTILITY(U,$J,358.3,41832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41832,1,3,0)
 ;;=3^Leiomyoma,Uterus,Intramural
 ;;^UTILITY(U,$J,358.3,41832,1,4,0)
 ;;=4^D25.1
 ;;^UTILITY(U,$J,358.3,41832,2)
 ;;=^267641
 ;;^UTILITY(U,$J,358.3,41833,0)
 ;;=D25.0^^159^2050^71
 ;;^UTILITY(U,$J,358.3,41833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41833,1,3,0)
 ;;=3^Leiomyoma,Uterus,Submucous
 ;;^UTILITY(U,$J,358.3,41833,1,4,0)
 ;;=4^D25.0
 ;;^UTILITY(U,$J,358.3,41833,2)
 ;;=^267640
 ;;^UTILITY(U,$J,358.3,41834,0)
 ;;=D25.2^^159^2050^72
 ;;^UTILITY(U,$J,358.3,41834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41834,1,3,0)
 ;;=3^Leiomyoma,Uterus,Subserosal
 ;;^UTILITY(U,$J,358.3,41834,1,4,0)
 ;;=4^D25.2
 ;;^UTILITY(U,$J,358.3,41834,2)
 ;;=^5002080
 ;;^UTILITY(U,$J,358.3,41835,0)
 ;;=D25.9^^159^2050^73
 ;;^UTILITY(U,$J,358.3,41835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41835,1,3,0)
 ;;=3^Leiomyoma,Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,41835,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,41835,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,41836,0)
 ;;=N94.3^^159^2050^96
 ;;^UTILITY(U,$J,358.3,41836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41836,1,3,0)
 ;;=3^Premenstrual Tension Syndrome
 ;;^UTILITY(U,$J,358.3,41836,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,41836,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,41837,0)
 ;;=Z11.51^^159^2050^99
 ;;^UTILITY(U,$J,358.3,41837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41837,1,3,0)
 ;;=3^Screening,HPV
 ;;^UTILITY(U,$J,358.3,41837,1,4,0)
 ;;=4^Z11.51
 ;;^UTILITY(U,$J,358.3,41837,2)
 ;;=^5062674
 ;;^UTILITY(U,$J,358.3,41838,0)
 ;;=Z12.4^^159^2050^103
 ;;^UTILITY(U,$J,358.3,41838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41838,1,3,0)
 ;;=3^Screening,malig Neop,Cervix (Pap)
 ;;^UTILITY(U,$J,358.3,41838,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,41838,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,41839,0)
 ;;=Z12.73^^159^2050^101
 ;;^UTILITY(U,$J,358.3,41839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41839,1,3,0)
 ;;=3^Screening,Malig Neop,Ovary
 ;;^UTILITY(U,$J,358.3,41839,1,4,0)
 ;;=4^Z12.73
 ;;^UTILITY(U,$J,358.3,41839,2)
 ;;=^5062692
 ;;^UTILITY(U,$J,358.3,41840,0)
 ;;=N84.0^^159^2050^105
 ;;^UTILITY(U,$J,358.3,41840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41840,1,3,0)
 ;;=3^Uterine Polyps
 ;;^UTILITY(U,$J,358.3,41840,1,4,0)
 ;;=4^N84.0
 ;;^UTILITY(U,$J,358.3,41840,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,41841,0)
 ;;=I05.8^^159^2051^17
 ;;^UTILITY(U,$J,358.3,41841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41841,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease NEC
 ;;^UTILITY(U,$J,358.3,41841,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,41841,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,41842,0)
 ;;=I10.^^159^2051^9
 ;;^UTILITY(U,$J,358.3,41842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41842,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,41842,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,41842,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,41843,0)
 ;;=I25.2^^159^2051^15
 ;;^UTILITY(U,$J,358.3,41843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41843,1,3,0)
 ;;=3^Old MI
 ;;^UTILITY(U,$J,358.3,41843,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,41843,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,41844,0)
 ;;=I25.10^^159^2051^4
 ;;^UTILITY(U,$J,358.3,41844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41844,1,3,0)
 ;;=3^Athscl Hrt Dis,Ntv Cor Art w/o AP
 ;;^UTILITY(U,$J,358.3,41844,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,41844,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,41845,0)
 ;;=I25.810^^159^2051^1
 ;;^UTILITY(U,$J,358.3,41845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41845,1,3,0)
 ;;=3^Athscl,CABG w/o AP
 ;;^UTILITY(U,$J,358.3,41845,1,4,0)
 ;;=4^I25.810
 ;;^UTILITY(U,$J,358.3,41845,2)
 ;;=^5007141
 ;;^UTILITY(U,$J,358.3,41846,0)
 ;;=I25.811^^159^2051^3
 ;;^UTILITY(U,$J,358.3,41846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41846,1,3,0)
 ;;=3^Athscl Hrt Dis of Trnsplt Hrt w/o AP
 ;;^UTILITY(U,$J,358.3,41846,1,4,0)
 ;;=4^I25.811
 ;;^UTILITY(U,$J,358.3,41846,2)
 ;;=^5007142
 ;;^UTILITY(U,$J,358.3,41847,0)
 ;;=I25.812^^159^2051^2
 ;;^UTILITY(U,$J,358.3,41847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41847,1,3,0)
 ;;=3^Athscl Byp Cor Art of Trnsplt Hrt w/o AP
 ;;^UTILITY(U,$J,358.3,41847,1,4,0)
 ;;=4^I25.812
 ;;^UTILITY(U,$J,358.3,41847,2)
 ;;=^5007143
 ;;^UTILITY(U,$J,358.3,41848,0)
 ;;=I35.0^^159^2051^10
